<DOC>
	<DOCNO>NCT02079441</DOCNO>
	<brief_summary>1 . To evaluate immune response vaccine infant IBD patient treat anti-TNF medication pregnancy compare infant IBD mother treat anti-TNF medication . 2 . To evaluate immune function B T cell 3 month one year age infant IBD patient treat anti-TNF medication pregnancy compare infant non anti-TNF treated mother . The secondary aim follow anti TNF drug level infant bear IBD patient treat anti-TNF medication pregnancy evaluate risk infection first year life population , compare child IBD patient treat anti-TNF medication pregnancy . Significance -The result study potential change clinical practice anti TNF treatment pregnancy follow-up infant born patient</brief_summary>
	<brief_title>Immune Function Offsprings Females With Inflammatory Bowel Disease ( IBD ) Treated With Anti-TNF Medications During Pregnancy</brief_title>
	<detailed_description />
	<mesh_term>Intestinal Diseases</mesh_term>
	<mesh_term>Inflammatory Bowel Diseases</mesh_term>
	<criteria>1 . Children born mother IBD treat antTNF medication , medication medically treat IBD pregnancy . 2 . Regular vaccination hepatitis B birth , 1 6 month age schedule nonlive vaccine 2,4 , 6 month age . 3 . Inform consent sign parent . 1 . Children intrauterine perinatal infection , congenital disease malformation . 2 . Absence immunization record . 3 . Known immune deficiency mother and/or child . 4 . Mothers hepatitis B</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>3 Months</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Anti- TNF</keyword>
	<keyword>inflammatory bowel disease</keyword>
	<keyword>pregnancy</keyword>
	<keyword>infant</keyword>
	<keyword>immunity</keyword>
	<keyword>Immune function</keyword>
</DOC>